Timolol in uncontrolled childhood glaucomas

Area of Science:

• Ophthalmology
• Pediatric Medicine
• Pharmacology

Background:

• Childhood glaucoma presents significant management challenges.
• Conventional glaucoma medications are often insufficient for pediatric cases.
• Timolol, effective in adults, was investigated for difficult childhood glaucoma.

Purpose of the Study:

• To evaluate the efficacy and safety of timolol in managing childhood glaucoma.
• To assess the impact of timolol on intraocular pressure and pulse rate in pediatric patients.

Main Methods:

• A prospective study involving 34 children with difficult-to-manage glaucoma.
• Timolol was added to existing maximal medical therapy.
• Patients were followed for up to 2.5 years, with outcomes and pulse rates monitored.

Main Results:

• Definite improvement was observed in 10 patients, with modest improvement in 11.
• 13 patients showed no substantial benefit from the addition of timolol.
• Children over 5 experienced a mean pulse rate reduction of 6 beats/minute; no change was noted in younger children.

Conclusions:

• Timolol demonstrates a potential benefit in some cases of childhood glaucoma, particularly in older children.
• The drug's efficacy is variable, and further investigation is warranted, especially in very young children.
• While generally well-tolerated, one patient discontinued due to a possible adverse effect.